Kevin Ward is a seasoned clinical research professional with extensive experience in various roles across multiple organizations. Currently serving as a Senior Clinical Research Associate at WuXi Clinical since July 2020, Kevin has previously held similar positions at Real Staffing, PRA Health Sciences, Inventiv Health, and MedSource, demonstrating a robust expertise in pre-study evaluations, site management, and compliance monitoring. Kevin's career boasts foundational roles at Eli Lilly and Company as a Medical Science Liaison, contributing significantly to oncology research. Educational qualifications include a B.S. in Biological Sciences from the University of California and a degree in Biology from UC Irvine, further supporting a strong background in clinical research methodologies and regulatory requirements.
This person is not in any offices
WuXi Clinical, a subsidiary of WuXi AppTec
1 followers
WuXi Clinical, a wholly owned subsidiary of WuXi AppTec, is a global Contract Research Organization (CRO) providing a comprehensive range of services in clinical development. We provide Phase I to Phase IV research & Bioequivalence (BE) studies for pharmaceuticals, biologics, and medical devices. With expertise spanning across all major therapeutic areas, we deliver the unique blend of an experienced team combined with data-driven insights and responsiveness for better outcomes. Our forward-thinking approach has allowed us to accelerate a variety of clinical projects ranging from first-in-human products to marketed drugs and devices.